Lone Star Bio
Filter News
Found 12,507 articles
-
Alafair Biosciences Announces VersaWrap® Tendon Protector Sales Milestone
5/23/2019
The rapid sales growth reflects expanding surgeon adoption and the significant clinical need for VersaWrap.
-
AlloVir is working to develop an allogeneic cell therapy to control infections in immunocompromised patients, typically after they undergo organ transplants.
-
Merck is buying all outstanding shares of Peloton, a clinical-stage oncology company, for an upfront payment of $1.05 billion in cash. Peloton will also be eligible for another $1.15 billion based on various regulatory and sales milestones.
-
ResMed Study Finds CPAP Adherence Improved by Remote Monitoring, Self-Monitoring across 3 Countries
5/21/2019
Study presented at ATS International Conference examined more than 4 million PAP users in U.S., Brazil, Mexico
-
Some of the biggest hubs for biotech and pharma fared poorly in the rankings due to housing affordability.
-
The company took its GSK-3B inhibitor into the clinic earlier this year. The drug is being studied in patients with refractory hematologic malignancies or solid tumors.
-
Vizient Endorses Legislation to Empower the FTC to Challenge Prescription Drug Patent Abuses
5/14/2019
This bipartisan Senate legislation targets “patent thickets” and other patent abuses that brand name pharmaceutical manufacturers utilize to delay market competition from generic and biosimilar drugs.
-
CITGO Raises More Than $2.2 Million for the Muscular Dystrophy Association
5/14/2019
Continues Historic Partnership as MDA's Largest Corporate Sponsor
-
Precision for Medicine To Provide Real-Time Laboratory Testing Services In Unique Lymphoma Patient Stratification Study
5/14/2019
The novel study will utilize Precision for Medicine's Houston-based CLIA certified lab to conduct real-time stratification studies on a specially selected group of B-Cell Lymphoma patients
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Hanger Announces Financial Results for the First Quarter of 2019
5/8/2019
Net revenue was $236.4 million for the three months ended March 31, 2019, compared to $234.0 million for the same period in 2018, reflecting a net revenue increase of 1.0 percent year-over-year.
-
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know your 'right opportunity' to consider a new job.
-
Shattuck Labs, Inc. Announces Initiation of Phase 1 Clinical Trial of SL-279252 (PD1/OX40L)
5/6/2019
SL-279252 is the first Agonist Redirected Checkpoint molecule to enter clinical development from the Shattuck pipeline.
-
Parks Associates Welcomes Sarah Jones, VP of Commercial Product, Great Call, as Keynote Speaker at Sixth-Annual Connected Health Summit: Independent Living And Wellness
5/6/2019
64% of consumers 50 and older are interested in home monitoring systems that can sense emergencies and notify caretakers
-
Savara Announces Molgradex Received Fast Track Designation by FDA for Treatment of Autoimmune Pulmonary Alveolar Proteinosis
5/6/2019
Topline results from the study are expected in June 2019.
-
Curbing the opioid crisis will continue to be a key focus for the FDA. Ned Sharpless talked about new packaging rules that are expected to help stem the concerns about too many opioids on the streets.
-
Apollo Endosurgery, Inc. Reports First Quarter 2019 Results
5/2/2019
Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET
-
According to a recent BioSpace survey, 93% of respondents are open to a new job for the right opportunity. Are you one of the 93%? If so, keep your eyes open for those opportunities and don't stop looking. You never know what may come your way!
-
Caris Life Sciences Acquires Pharmatech
5/1/2019
Purchase of leading Just-In-Time clinical trials recruitment service will benefit patients, physicians and drug developers by connecting cancer patients to the right trials faster
-
Cell Medica Collaborators, Baylor College of Medicine and Texas Children’s Hospital, Present Preclinical Data for an off-the-shelf CAR-NKT Therapy Platform at American Society of Gene & Cell Therapy 22nd Annual Meeting
5/1/2019
Allogeneic “off the shelf” chimeric antigen receptor-natural killer T cell (CAR-NKT) therapy platform could overcome significant challenges of current autologous CAR-T therapies